Sino Biopharmaceutical Statistics
Total Valuation
HKG:1177 has a market cap or net worth of HKD 69.56 billion. The enterprise value is 75.94 billion.
Market Cap | 69.56B |
Enterprise Value | 75.94B |
Important Dates
The last earnings date was Thursday, March 27, 2025.
Earnings Date | Mar 27, 2025 |
Ex-Dividend Date | Jun 16, 2025 |
Share Statistics
HKG:1177 has 17.88 billion shares outstanding. The number of shares has decreased by -1.26% in one year.
Current Share Class | n/a |
Shares Outstanding | 17.88B |
Shares Change (YoY) | -1.26% |
Shares Change (QoQ) | -1.25% |
Owned by Insiders (%) | 50.59% |
Owned by Institutions (%) | 18.09% |
Float | 8.83B |
Valuation Ratios
The trailing PE ratio is 34.85 and the forward PE ratio is 20.55. HKG:1177's PEG ratio is 1.34.
PE Ratio | 34.85 |
Forward PE | 20.55 |
PS Ratio | 2.32 |
PB Ratio | 2.05 |
P/TBV Ratio | 2.26 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | 1.34 |
Enterprise Valuation
EV / Earnings | 20.39 |
EV / Sales | 2.47 |
EV / EBITDA | 11.91 |
EV / EBIT | 14.13 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.23.
Current Ratio | 1.26 |
Quick Ratio | 1.02 |
Debt / Equity | 0.23 |
Debt / EBITDA | 1.60 |
Debt / FCF | n/a |
Interest Coverage | 17.51 |
Financial Efficiency
Return on equity (ROE) is 11.82% and return on invested capital (ROIC) is 6.25%.
Return on Equity (ROE) | 11.82% |
Return on Assets (ROA) | 5.01% |
Return on Invested Capital (ROIC) | 6.25% |
Return on Capital Employed (ROCE) | 11.27% |
Revenue Per Employee | 1.26M |
Profits Per Employee | 152,772 |
Employee Count | 24,379 |
Asset Turnover | 0.45 |
Inventory Turnover | 2.44 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +30.64% in the last 52 weeks. The beta is 0.75, so HKG:1177's price volatility has been lower than the market average.
Beta (5Y) | 0.75 |
52-Week Price Change | +30.64% |
50-Day Moving Average | 3.32 |
200-Day Moving Average | 3.22 |
Relative Strength Index (RSI) | 68.77 |
Average Volume (20 Days) | 109,370,322 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1177 had revenue of HKD 30.72 billion and earned 3.72 billion in profits. Earnings per share was 0.20.
Revenue | 30.72B |
Gross Profit | 25.04B |
Operating Income | 5.50B |
Pretax Income | 5.62B |
Net Income | 3.72B |
EBITDA | 6.50B |
EBIT | 5.50B |
Earnings Per Share (EPS) | 0.20 |
Balance Sheet
The company has 15.53 billion in cash and 10.41 billion in debt, giving a net cash position of 5.12 billion or 0.29 per share.
Cash & Cash Equivalents | 15.53B |
Total Debt | 10.41B |
Net Cash | 5.12B |
Net Cash Per Share | 0.29 |
Equity (Book Value) | 45.52B |
Book Value Per Share | 1.90 |
Working Capital | 5.46B |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 81.51%, with operating and profit margins of 17.91% and 12.12%.
Gross Margin | 81.51% |
Operating Margin | 17.91% |
Pretax Margin | 18.28% |
Profit Margin | 12.12% |
EBITDA Margin | 21.16% |
EBIT Margin | 17.91% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 2.03%.
Dividend Per Share | 0.08 |
Dividend Yield | 2.03% |
Dividend Growth (YoY) | -25.00% |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 1.26% |
Shareholder Yield | 3.29% |
Earnings Yield | 5.35% |
FCF Yield | n/a |
Stock Splits
The last stock split was on July 20, 2020. It was a forward split with a ratio of 1.5.
Last Split Date | Jul 20, 2020 |
Split Type | Forward |
Split Ratio | 1.5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |